Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats (Q50615721)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 August 2011
edit
Language Label Description Also known as
English
Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats
scientific article published on 5 August 2011

    Statements

    Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit